We demonstrate that AKR1B10 acts as a crucial suppressor of CRC metastasis by functioning as a bona fide endogenous activator of the PP2A holoenzyme through its redox enzymatic activity and direct interaction with PP2Ac. Here, AKR1B10 is linked to colorectal carcinoma.